University of Texas, MD Anderson — Houston, Texas

University of Texas, MD Anderson is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.

University of Texas, MD Anderson has participated in 3 clinical trials with 1 currently active.

Therapeutic areas: Hodgkin Lymphoma, Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma), B-Cell Lymphoma.

Sponsors: Mirati Therapeutics Inc., Pharmacyclics LLC., UroMems SAS.

Sponsor Feasibility Report

Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Texas, MD Anderson?

University of Texas, MD Anderson has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Texas, MD Anderson conducted?

University of Texas, MD Anderson has 3 clinical trials on record, with 1 currently active. Their work covers Hodgkin Lymphoma, Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma), B-Cell Lymphoma.

Is University of Texas, MD Anderson accredited by Crixeo Health?

University of Texas, MD Anderson has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Texas, MD Anderson?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.